Uncategorized
Generic latanoprost may improve patient adherence with lower costs vs. brand-name agents
Switching from a brand-name prostaglandin analogue to generic latanoprost may improve patient adherence in the treatment of open-angle glaucoma, according to a study presented at the American Glaucoma Society annual meeting.“It is well known that medication adherence is a major challenge for many patients,” Joshua D. Stein, MD, MS, said at the meeting, delivering study results that were published in Ophthalmology. “There are a number of reasons why patients struggle with adherence, one of which is medication costs.”